Categories

All Analgesic Analgesic Combination Antianginal Antibiotic Anticancer Anticoagulant Anticonvulsant Antidepressant Antidiabetic Antidiarrheal Antihypertensive Antimalarial Antiparasitic Antiparkinson Antiplatelet Antipsychotic Anxiolytic Bronchodilator Cardiovascular Corticosteroid Diuretic Emergency Endocrine Gastrointestinal Immunomodulator Immunosuppressant Minerals Neurological NSAID Oncology – Targeted therapy Psychiatric Sedative/Hypnotic Sympathomimetic Vitamins

Anticancer Class

Clear
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing 3 drugs starting with: B

Bevacizumab

Brand: Avastin (global) / Bevacizumab (IN/BD)
Class: Anticancer
Subclass: VEGF monoclonal antibody
PK: t½ 480 hours | Clearance: hepatic
Max Dose: 15 day
life-threatening
AE: Hypertension, proteinuria, arterial thromboembolism, GI perforation

Binimetinib

Brand: Mektovi (global)
Class: Anticancer
Subclass: MEK inhibitor
PK: t½ 9 hours | Clearance: hepatic
Max Dose: 90 day
severe
AE: Retinal pigment epithelial detachment, CPK elevations, hepatotoxicity, diarrhea

Brigatinib

Brand: Alunbrig (global)
Class: Anticancer
Subclass: ALK inhibitor (2nd gen)
PK: t½ 26 hours | Clearance: hepatic
Max Dose: 180 day
severe
AE: Pneumonitis (early onset), hypertension, visual disturbances, hyperglycemia, myalgia